| Karen Barcklay, MD | |
|
6051 E 34th St, Yuma, AZ 85365-4889 | |
| (858) 775-4195 | |
| Not Available |
| Full Name | Karen Barcklay |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 27 Years |
| Location | 6051 E 34th St, Yuma, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881825164 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 29446 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fortuna Medical Group | 2264721968 | 3 |
News Archive
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
Parents with children conceived via IVF, IUI or using infertility medication can rest assured that treatment has no impact on childhood development.
New figures from the Schools Health Education Unit show that since 1991, there has been a decline in the numbers of 12-15 year olds that report playing pool and snooker.
Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.
› Verified 7 days ago
| Entity Name | Fortuna Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386044477 PECOS PAC ID: 2264721968 Enrollment ID: O20160519001610 |
News Archive
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
Parents with children conceived via IVF, IUI or using infertility medication can rest assured that treatment has no impact on childhood development.
New figures from the Schools Health Education Unit show that since 1991, there has been a decline in the numbers of 12-15 year olds that report playing pool and snooker.
Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.
› Verified 7 days ago
| Entity Name | Theoria Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609362375 PECOS PAC ID: 5395098339 Enrollment ID: O20221024002456 |
News Archive
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
Parents with children conceived via IVF, IUI or using infertility medication can rest assured that treatment has no impact on childhood development.
New figures from the Schools Health Education Unit show that since 1991, there has been a decline in the numbers of 12-15 year olds that report playing pool and snooker.
Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Barcklay, MD 7487 E 25th St, Yuma, AZ 85365-8877 Ph: (928) 342-8256 | Karen Barcklay, MD 6051 E 34th St, Yuma, AZ 85365-4889 Ph: (858) 775-4195 |
News Archive
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
Parents with children conceived via IVF, IUI or using infertility medication can rest assured that treatment has no impact on childhood development.
New figures from the Schools Health Education Unit show that since 1991, there has been a decline in the numbers of 12-15 year olds that report playing pool and snooker.
Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.
› Verified 7 days ago
Trevor Saxman, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 2989 E Arow St, Yuma, AZ 85365 Phone: 623-632-7210 | |
Abigail Vargo, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 990 D St, Yuma, AZ 85365 Phone: 928-328-2666 Fax: 928-328-3838 | |
Dr. Conan Joyce Gonzalez, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Bmc Yuma, 2917 East Hart Street, Yuma, AZ 85365 Phone: 928-269-2416 | |
Dr. David Smock, MD General Practice Medicare: Medicare Enrolled Practice Location: 11274 S Fortuna Rd Ste I4, 558 Abbott St Ste A, Yuma, AZ 85367 Phone: 928-345-2150 Fax: 928-345-2151 | |
Stephen Replogle, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 11871 S Fortuna Rd, Yuma, AZ 85367 Phone: 928-342-9020 Fax: 928-342-2158 | |
Hassan Askari, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2475 S Avenue A, Yuma, AZ 85364 Phone: 928-344-9000 Fax: 928-344-9002 |